Navigation Links
Natural Alternatives International, Inc. Announces Fiscal 2009 Q4 and Full Year Results
Date:9/22/2009

SAN MARCOS, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.1 million or $0.58 per diluted share on net sales from continuing operations of $73.9 million for the fiscal year ended June 30, 2009. The fiscal 2009 results include a net loss from discontinued operations of $3.9 million or $0.55 per diluted share primarily related to the write-down of goodwill and intangible assets, and severance and other business related exit costs.

Fiscal 2009 net sales from continuing operations decreased $7.9 million from $81.8 million for fiscal 2008. This decrease included a decline in contract manufacturing sales of $6.6 million or 8% primarily from the impact of current economic conditions and inventory management by many of our customers. These sales decreases were partially offset by increased sales volumes from other existing customers and new customer sales and income related to a sublicense agreement for the distribution of Beta-Alanine from within our patent estate. Net sales from our branded products declined $1.2 million or 31% during fiscal 2009 as compared to the prior fiscal year associated with the continued softening of the Pathway to Healing(R) product line. The net loss from continuing operations for fiscal 2009 was $220,000 or $0.03 per diluted share as compared to net income of $912,000 for fiscal 2008 or $0.13 per diluted share.

Net sales from continuing operations for the fourth quarter ended June 30, 2009 totaled $19.4 million and represented a decrease of $2.1 million as compared to net sales of $21.5 million in the fourth quarter of fiscal 2008. Net income from continuing operations in the fourth quarter of fiscal 2009 was $1.2 million or $0.17 per diluted share as compared to a net loss of $3,000 or $0.00 per share in the fourth quarter of fiscal 2008. The increase in net income from continuing operations was attributable to an improved product sales mix, reduced labor and other manufacturing costs and lower selling, general and administrative expenses associated with our cost reduction and organizational consolidation efforts during fiscal 2009. During the second half of fiscal 2009, our cost reduction program resulted in operating expense savings of approximately $3.0 million compared to our cost structure in the comparable prior year period. We expect our cost reduction program to further reduce our operating overhead costs in fiscal 2010 by approximately $3.5 million as compared to fiscal 2009.

The net loss from discontinued operations of $115,000 or $0.02 per diluted share in the fourth quarter of fiscal 2009 compared to a net loss of $165,000 or $0.02 per diluted share in the fourth quarter of fiscal 2008. Overall, net income for the fourth quarter was $1.1 million or $0.16 per diluted share as compared to a net loss of $168,000 or $0.02 per diluted share in the comparable quarter last year.

On July 31, 2009, we sold substantially all of the remaining assets of our wholly owned subsidiary, Real Health Laboratories, Inc. (RHL), related to its wholesale and direct-to-consumer business to PharmaCare US Inc. and PharmaCare Laboratories Pty Ltd. for a cash purchase price of $500,000. As additional compensation, RHL may receive up to an additional $500,000 from the buyers as a conditional earn-out if the RHL business acquired by the buyers meets or exceeds certain budgeted profitability criteria during the period August 1, 2009 through July 31, 2010. The company anticipates the remaining wind-down business activity of RHL will terminate during the second half of fiscal 2010.

As of June 30, 2009 NAI had cash and certificates of deposit of $4.7 million and working capital of $13.9 million compared to $3.5 million and $18.4 million, respectively, as of June 30, 2008. As of June 30, 2009, we had $5.2 million available under our working capital line of credit and were in full compliance with all lender covenants under the terms of our banking agreement.

Chairman and Chief Executive Officer Mark LeDoux stated, "We are pleased to report the improvement in the operating results of NAI. While the current economic conditions continue to challenge the economy at large, we believe our hard work to partner with our customers to develop innovative products and continuing efforts to push initiatives for intelligent cost management are beginning to bear fruit. During this past quarter, we focused on instituting further cost reduction programs including the elimination of certain personnel and non-essential or redundant business activities. We have also sharply reduced our debt as well as enhanced our inventory turnover through better operational oversight. The restoration of focus to our core mission of being the best custom contract manufacturer of dietary supplements for our esteemed clients is sharpening our vision and has helped us sustain operational profitability. We believe that we have positioned the company for profitable performance for fiscal 2010. As we enter our thirtieth year of operations in the U.S. and eleventh year in Switzerland, we remain optimistic about our future growth opportunities and intend to continue to leverage our certified manufacturing facilities and excellent customer service reputation to expand our distribution and customer base."

NAI, headquartered in San Marcos, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website athttp://www.nai-online.com.

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to our future financial and operating results, including the amount of our future revenue and profits and our future financial condition, our ability to reduce operating costs, expand our contract manufacturing business, and develop, maintain or increase sales to new and existing customers, the timing of the completion of the wind-down of RHL, and our ability to successfully leverage our manufacturing facilities, as well as future economic conditions and the impact of such conditions on our business. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI's financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

CONTACT - Kenneth Wolf, Chief Financial Officer, Natural Alternatives International, Inc., at 760-736-7700 or investor@nai-online.com.

Web site: http://www.nai-online.com


                      NATURAL ALTERNATIVES INTERNATIONAL, INC.
                        CONDENSED CONSOLIDATED BALANCE SHEETS
                                     (In thousands)

                                                     June 30,         June 30,
                                                       2009             2008
                                                       ----             ----

    ASSETS
    Cash and cash equivalents                         $4,694           $3,518
    Accounts receivable, net                           5,685            6,401
    Inventories, net                                   9,320           14,135
    Income tax receivable                                  2            1,354
    Current assets of discontinued operations          1,187            6,299
    Other current assets                               1,259            1,223
                                                       -----            -----
        Total current assets                          22,147           32,930
    Property and equipment, net                       14,133           12,823
    Other noncurrent assets, net                         159              160
                                                         ---              ---
        Total Assets                                 $36,439          $45,913
                                                     =======          =======

    LIABILITIES AND STOCKHOLDERS' EQUITY
    Accounts payable and accrued liabilities          $6,982          $10,034
    Current portion of long-term debt                    669            2,730
    Current liabilities of discontinued operations       599            1,724
    Deferred rent                                      1,054            1,164
    Deferred income taxes                                  -               61
    Long-term debt, less current portion                 598                -
    Long-term pension liability                          505              198
                                                         ---              ---
        Total Liabilities                             10,407           15,911
                                                      ------           ------
    Stockholders' Equity                              26,032           30,002
                                                      ------           ------
        Total Liabilities and Stockholders' Equity   $36,439          $45,913
                                                     =======          =======



                  NATURAL ALTERNATIVES INTERNATIONAL, INC.
             CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME
                    (In thousands, except per share data)
                                 (Unaudited)

                  Three Months Ended             Twelve Months Ended
                       June 30,                        June 30,
                 ---------------------           -------------------
                 2009             2008           2009           2008
                 ----             ----           ----           ----
    NET
     SALES     $19,429  100.0% $21,547  100.0% $73,919  100.0% $81,755  100.0%
    Cost
     of goods
     sold       16,303   83.9%  18,316   85.0%  64,514   87.3%  68,843   84.2%
                ------   ----   ------   ----   ------   ----   ------   ----
    Gross
     profit      3,126   16.1%   3,231   15.0%   9,405   12.7%  12,912   15.8%

    Selling,
     general &
     administrative
     expenses    1,828    9.4%   2,950   13.7%   9,008   12.2%  11,838   14.5%
                 -----           -----           -----          ------

    INCOME
     FROM
     CONTINUING
     OPERATIONS  1,298    6.7%     281    1.3%     397    0.5%   1,074    1.3%

    Other
     Income
     (expense),
     net            38    0.2%     (44)  -0.2%    (524)  -0.7%     102    0.1%
                   ---    ---      ---   ----     ----   ----      ---    ---
    INCOME
     (LOSS)
     BEFORE
     INCOME
     TAXES
     AND
     DISCONTINUED
     OPERATIONS  1,336    6.9%     237    1.1%    (127)  -0.2%   1,176    1.4%

    Provision
     For
     Income
     taxes          96             240              93             264
                   ---             ---             ---             ---
    INCOME
     (LOSS)
     BEFORE
     DISCONTINUED
     OPERATIONS  1,240    6.4%      (3)   0.0%    (220)  -0.3%     912    1.1%

    LOSS
     FROM
     DISCONTINUED
     OPERATIONS,
     NET OF
     TAX          (115)  -0.6%    (165)  -0.8%  (3,860)  -5.2%  (1,283)  -1.6%
                  ----            ----          ------          ------

    NET INCOME
     (LOSS)     $1,125           $(168)        $(4,080)          $(371)
                ======           =====         =======           =====


    NET
     INCOME
     (LOSS)
     PER
     COMMON
     SHARE:
    Basic:
    Continuing
     Operations  $0.18          ($0.00)         ($0.03)          $0.13
    Discontinued
     Operations ($0.02)         ($0.02)         ($0.55)         ($0.18)
                ------          ------          ======          ======
    NET INCOME
     (LOSS)      $0.16          ($0.02)         ($0.58)         ($0.05)
                 =====          ======          ======          ======

    Diluted:
    Continuing
     Operations  $0.17          ($0.00)         ($0.03)          $0.13
    Discontinued
     Operations ($0.02)         ($0.02)         ($0.55)         ($0.18)
                 ------          ------          ======          ======
    NET INCOME
     (LOSS)      $0.16          ($0.02)         ($0.58)         ($0.05)
                 =====          ======          ======          ======

    WEIGHTED
     AVERAGE
     COMMON
     SHARES
     OUTSTANDING:
    Basic        7,066           7,023           7,056           6,983
                 =====           =====           =====           =====
    Diluted      7,106           7,023           7,056           7,038
                 =====           =====           =====           =====




'/>"/>
SOURCE Natural Alternatives International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Head Lice Meet Their Natural Match - Leading Experts Say Safe Solution Proves Best for Lice and Nit Removal
2. Traditional Chinese Medicine and Acupuncture Continue to Grow in Popularity Due to Focus on Natural Health
3. Filmmaker John Hughes' Recent Untimely Death is a Call for Better Understanding of Sudden Cardiac Death, the Leading Cause of Natural Death in the U.S.
4. Protica Teams With UNFI/Select Nutrition to distribute All-Natural Protein Shot, Proasis
5. Nuvilex, Inc. Announces Reme-Flu(TM) as Trade Name for All-Natural Flu Remedy Formula
6. Rest Easy, the Safe, All-Natural Bed Bug Travel Spray
7. Jarrow Formulas, Inc. to Unveil Children's Natural Health Products at Upcoming Natural Products Expo East Show in Boston
8. Nuvilex, Inc. Finalizes Joint Venture Agreement for the Development of Broad Spectrum All-Natural Flu Remedies
9. XanGo Introduces a New Dietary Supplement That Restores Youthful Vigor - Naturally
10. Lose Weight, Lower Cholesterol, and Stay Healthy at School: Natural Solutions Magazine Shows You How
11. New Online Health Encyclopedia NaturalPedia.com Distills Knowledge From Industrys Top Authors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Tampa, FL (PRWEB) , ... December 08, 2016 ... ... been awarded accreditation with distinction by the Undersea and Hyperbaric Medical Society (UHMS), ... patients with advanced care and patient safety. Only a few hospitals and facilities ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc ... Language Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: ... , Results of the comparative usability study demonstrate that a dictation-based method (“NLP ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading ... has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE ... Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage Lung ...
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and The Chopra ... weight loss and wellness program, at their world headquarters of Omni La Costa Resort ... long-term results to anyone seeking weight loss, personal development, a healthy lifestyle, or mental ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, the leading ... consumer health products, today announced that it had joined the Pharmaceutical Supply Chain ... organization to unite pharmaceutical and healthcare companies that share a vision of better, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... LONDON , December 9, 2016 ... ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac ... External Defibrillators, Wearable Cardioverter Defibrillators The ... grow at a CAGR of 5.3% from 2016-2020 ... is expected to grow at a CAGR of ...
(Date:12/9/2016)... Research and Markets has announced the addition of the "High ... offering. ... analyses the market by the following Technology Types: Label-Free Technology, Cell-Based Assay, ... Canada , Japan , Europe ... , and Rest of World. Annual estimates and forecasts ...
(Date:12/9/2016)... Research and Markets has announced the ... 2021" report to their offering. ... Market growth can be ... the pharmaceutical and biotechnology industry and technological advancements like automation ... markets and growing research activities in toxicology and stem cells ...
Breaking Medicine Technology: